of 1 Next >
Results Found: 9
  • NYU Dataset

    TeleQuit MH Data

    Alternate Title(s)
    TQMH
    Authors
    Scott Sherman
    Description

    The TeleQuit MH dataset was collected for a type-II hybrid effectiveness-implementation study that evaluated a smoking cessation telephone care program for mental health patients in the Veterans Health Administration (VHA). The primary objectives were to evaluate the adaption, implementation, and maintenance of the smoking cessation program; determine its effectiveness at long-term abstinence; and...

    Subject
    Health Care System
    Mental Health
    Access Rights
    Author Approval Required
  • NYU Dataset

    CHART New York Smoking-Cessation Interventions for Urban Hospital Patients Dataset

    Authors
    Donna Shelley
    Erin Rogers
    Scott Sherman
    Description

    The Consortium of Hospitals Advancing Research on Tobacco (CHART) is a network of six projects and a coordinating center aimed at assessing the effectiveness and cost-effectiveness of smoking cessation interventions initiated during hospitalizations and continued post-discharge. The CHART New York Smoking-Cessation Interventions for Urban Hospital Patients trial looked at the effectiveness of a pro-active,...

    Subject
    Health Care System
    Health Status
    Risk Factors
    Access Rights
    Application Required
    Author Approval Required
  • NYU Dataset

    Counseling African Americans to Control Hypertension

    Alternate Title(s)
    CAATCH
    Authors
    Gbenga Ogedegbe
    Joseph Schwartz
    Jonathan N. Tobin
    Senaida Fernandez
    2 more author(s)...
    Description

    This dataset was generated from a 12-month two-arm cluster-randomized controlled trial, Counseling African Americans to Control Hypertension (CAATCH). The goal of the study was to evaluate the effectiveness of a multilevel, multicomponent, evidence-based intervention compared with usual care in improving blood pressure control among hypertensive blacks who receive care in community health centers....

    Subject
    Chronic Disease
    Health Care System
    Risk Factors
    Access Rights
    Application Required
    Author Approval Required
  • NYU Dataset

    Dataset from the Financial Incentives for Weight Reduction Randomised Controlled Trial

    Alternate Title(s)
    FIReWoRk Trial
    Authors
    Melanie Jay
    Stephanie L. Orstad
    Soma Wali
    Judith Wylie-Rosett
    6 more author(s)...
    Description

    The Financial Incentives for Weight Reduction (FIReWoRk) trial assessed the comparative effectiveness of financial incentives on the attainment of weight loss goals among adult patients (aged 18 to 70 years old) with obesity from neighborhoods with low socioeconomic status in New York City and Los Angeles. Eligible patients were identified at 3 primary care locations: NYC Health+Hospitals – Bellevue,...

    Subject
    Chronic Disease
    Risk Factors
    Access Rights
    Free to All
  • NYU Dataset

    Task Shifting and Blood Pressure Control in Ghana

    Alternate Title(s)
    TASSH Study
    Authors
    Gbenga Ogedegbe
    Jacob Plange-Rhule
    Joyce Gyamfi
    William Chaplin
    9 more author(s)...
    Description

    The dataset includes a total of 757 patients with uncontrolled hypertension who were enrolled into the Task Shifting and Blood Pressure Control in Ghana (TASSH) study through 32 community health centers in Ghana. TASSH was a randomized controlled trial that compared the outcomes of 2 interventions to reduce systolic blood pressure (SBP): standard of care treatment available through public health insurance...

    Subject
    Chronic Disease
    Health Care System
    Access Rights
    Free to All
  • NYU Dataset

    Extended-Release Naltrexone vs. Buprenorphine for Opioid Treatment

    Alternate Title(s)
    X:BOT
    Authors
    John Rotrosen
    Patricia Novo
    Joshua D. Lee
    Description

    Survey and clinical data were obtained from 570 participants in a randomized controlled trial to evaluate the comparative effectiveness of an extended release injectable naltrexone (XR-NTX, Vivitrol®) against buprenorphine-naloxone (BUP-NX, Suboxone®) as treatments for opioid dependence. The study was conducted in 8 NIDA Clinical Trials Network-affiliated community treatment programs in the United...

    Subject
    Mental Health
    Access Rights
    Free to All
  • NYU Dataset

    Comparison of Treatment Retention of Adults with Opioid Addiction Managed With Extended-Release Buprenorphine vs Daily Sublingual Buprenorphine-Naloxone at Time of Release From Jail

    Authors
    Joshua D. Lee
    Mia Malone
    Ryan McDonald
    Anna Cheng
    10 more author(s)...
    Description

    In a pilot open-label randomized controlled trial, investigators compared the effectiveness and acceptability of buprenorphine extended-release (XRB) drugs versus daily sublingual buprenorphine-naloxone (SLB) to treat opioid use disorders in adult prisoners during incineration and after community re-entry. Eligible participants met the following inclusion criteria: Over 18 years old Met Diagnostic...

    Subject
    Mental Health
    Access Rights
    Application Required
    Author Approval Required
  • NYU Dataset

    CariedAway Pragmatic Non-inferiority Trial of Silver Diamine Fluoride

    Authors
    Ryan Richard Ruff
    Richard Niederman
    Description

    The CariedAway project was a cluster randomized pragmatic clinical trial that investigated the non-inferiority of silver diamine fluoride (SDF) versus glass ionomer sealants in the arrest and incidence of dental caries in children when applied through a school-based oral disease prevention program. Secondary objectives of the CariedAway trial were to (1) assess the non-inferiority of SDF when applied...

    Subject
    Chronic Disease
    Health Care System
    Access Rights
    Application Required
    Author Approval Required
  • NYU Dataset

    A Multicenter, Adaptive, Randomized Controlled Platform Trial of the Safety and Efficacy of Antithrombotic Strategies in Hospitalized Adults with COVID-19

    Alternate Title(s)
    Accelerating COVID-19 Therapeutic Interventions and Vaccines 4 ACUTE, ACTIV4-ACUTE, ACTIV4A
    Authors
    Matthew D. Neal
    Judith S. Hochman
    Scott Solomon
    Mikhail Kosiborod
    1 more author(s)...
    Description

    Accelerating COVID-19 Therapeutic Interventions and Vaccines 4 ACUTE (ACTIV4A) is a randomized, open label, adaptive platform trial that compares the effectiveness of several antithrombotic strategies for the prevention of adverse outcomes in COVID-19 positive inpatients. Investigators assessed outcomes such as the number of days that a patient is alive and free of organ support through the first 21...

    Subject
    COVID-19
    Infectious Disease
    Access Rights
    Fee Required
    Application Required
    Author Approval Required